6 min listen
Use of a rare disease patient registry in long-term post-authorisation drug studies
Use of a rare disease patient registry in long-term post-authorisation drug studies
ratings:
Length:
9 minutes
Released:
May 5, 2018
Format:
Podcast episode
Description
Dr. Diana Bilton joins The Lancet Respiratory Medicine to discuss how the use of rare disease patient registries helps with long term drug studies after drug authorisation.
Released:
May 5, 2018
Format:
Podcast episode
Titles in the series (100)
The Lancet Respiratory Medicine: June 04, 2013 by The Lancet Respiratory Medicine in conversation with